Ortiz Drops Critical Elements from CIRM Oversight Bill
Major changes will be made in legislation to tighten oversight of the California stem cell agency, including the elimination of provisions that could have required royalties as high as 50 percent on inventions financed with state funds.
The moves may well be an initial step in a compromise on the sweeping legislation by California State Sen. Deborah Ortiz
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.